Adrian Gottschalk

Biogen Idec, Inc.

14 Cambridge Center

Cambridge, MA 02142

United States

SCHOLARLY PAPERS

3

DOWNLOADS

216

SSRN CITATIONS
Rank 47,383

SSRN RANKINGS

Top 47,383

in Total Papers Citations

0

CROSSREF CITATIONS

11

Scholarly Papers (3)

1.

Assessing the Safety and Efficacy of the Fda: The Case of the Prescription Drug User Fee Acts

NBER Working Paper No. w11724
Number of pages: 42 Posted: 19 Jan 2006 Last Revised: 13 Mar 2013
University of Chicago, Massachusetts Institute of Technology (MIT) - Sloan School of Management, Biogen Idec, Inc. and affiliation not provided to SSRN
Downloads 93 (292,074)

Abstract:

Loading...

2.

Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the Fda

NBER Working Paper No. w11425
Number of pages: 40 Posted: 06 Jul 2005 Last Revised: 30 Oct 2014
Ernst R. Berndt, Adrian Gottschalk and Matthew W. Strobeck
Massachusetts Institute of Technology (MIT) - Sloan School of Management, Biogen Idec, Inc. and affiliation not provided to SSRN
Downloads 73 (337,821)

Abstract:

Loading...

3.

Assessing the Impacts of the Prescription Drug User Fee Acts (Pdufa) on the Fda Approval Process

NBER Working Paper No. w10822
Number of pages: 33 Posted: 19 Oct 2004 Last Revised: 02 Jun 2013
Massachusetts Institute of Technology (MIT) - Sloan School of Management, Biogen Idec, Inc., University of Chicago and affiliation not provided to SSRN
Downloads 50 (407,451)

Abstract:

Loading...